Director, 10% OwnerCIK 0001697316
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | BIOS Fund I, LPDirector, 10% Owner |  ACTUACTUATE THERAPEUTICS, INC.Grant or award | A | — 65.0K sh | Oct 30, 2026 traded Oct 28, 2026 | |
BIOS Fund I, LPDirector, 10% Owner |
| ACTUACTUATE THERAPEUTICS, INC. Grant or award |
| A |
| — 87.7K sh |
| Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 195.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 368.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 36.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 269.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.5K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 126.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.0K sh | Oct 30, 2026 traded Oct 28, 2026 |